Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Affinity and Avidity01:41

Affinity and Avidity

38.7K
Overview
38.7K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

464
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
464
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

419
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
419
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

576
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
576
Drug Binding to Blood Components01:30

Drug Binding to Blood Components

512
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
512

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CoarsenConf: Equivariant Coarsening with Aggregated Attention for Molecular Conformer Generation.

Journal of chemical information and modeling·2024
Same author

Investigating the behavior of diffusion models for accelerating electronic structure calculations.

Chemical science·2024
Same author

Factors Associated With Higher Utilization of Outpatient Physical Therapy for Patients Who Have Undergone Primary Total Joint Arthroplasty: A Retrospective Cohort Study.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery·2024
Same author

Chemical reaction networks and opportunities for machine learning.

Nature computational science·2024
Same author

An Ecosystem for Digital Reticular Chemistry.

ACS central science·2023
Same author

Machine learning with persistent homology and chemical word embeddings improves prediction accuracy and interpretability in metal-organic frameworks.

Scientific reports·2021

相关实验视频

Updated: Jan 27, 2026

Determining the Ice-binding Planes of Antifreeze Proteins by Fluorescence-based Ice Plane Affinity
08:46

Determining the Ice-binding Planes of Antifreeze Proteins by Fluorescence-based Ice Plane Affinity

Published on: January 15, 2014

9.6K

基于结构的药物设计中扩散模型的通用约束性亲和指导.

Yue Jian1, Curtis Wu2, Danny Reidenbach3

  • 1Department of Chemical & Biomolecular Engineering, University of California, Berkeley, Berkeley, California 94720, United States.

Journal of chemical information and modeling
|January 26, 2026
PubMed
概括

我们开发了BADGER,这是一个框架,用于增强基于结构的药物设计的扩散模型. 它通过指导分子生成来提高联体蛋白结合亲和力,从而导致更好的药物候选者.

更多相关视频

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.2K
Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis
10:22

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

Published on: August 15, 2013

31.3K

相关实验视频

Last Updated: Jan 27, 2026

Determining the Ice-binding Planes of Antifreeze Proteins by Fluorescence-based Ice Plane Affinity
08:46

Determining the Ice-binding Planes of Antifreeze Proteins by Fluorescence-based Ice Plane Affinity

Published on: January 15, 2014

9.6K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.2K
Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis
10:22

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

Published on: August 15, 2013

31.3K

科学领域:

  • 计算化学是一种计算化学.
  • 药物发现 药物发现
  • 医学中的人工智能

背景情况:

  • 基于结构的药物设计 (SBDD) 使用计算方法创建针对特定蛋白质的分子.
  • 扩散模型在SBDD中显示出希望,但往往缺乏对结合亲和力的精确控制.
  • 现有的模型可能在联体生成过程中不够优先考虑结合亲和力.

研究的目的:

  • 在SBDD中引入BADGER,这是SBDD中扩散模型的新型约束亲和指导框架.
  • 为了提高扩散模型的控制和有效性,在产生高亲缘关系联体方面.
  • 为了使药物候选物的设计具有改进的结合特性.

主要方法:

  • BADGER采用两种策略:基于梯度的亲和信号的分类器指导和将亲和条件纳入培训的无分类器指导.
  • 该框架被设计为现有扩散模型的插入运行模块.
  • 扩展到多重约束指导,优化结合亲和力,药物相似性 (QED) 和合成可访问性 (SA).

主要成果:

  • 与以前的方法相比,BADGER在联体蛋白结合亲和力中表现出高达60%的改善.
  • 通过结合亲和力引导实现可控制的配体生成.
  • 通过优化多个约束,成功设计了现实的和可合成的候选药物.

结论:

  • 贝杰 (BADGER) 在基于结构的药物设计中显著提升了扩散模型的能力.
  • 该框架提供了一个强大的工具,用于生成强效和特定的候选药物.
  • 多重约束优化使得能够设计具有高结合亲和力的类似药物和可合成分子.